To our knowledge STIM proteins have not previously been assessed in the streptoztocin (STZ)- induced rat model of AD nor have their alterations been assessed after Carbamylated Erythropoietin-Fc (CEPO-FC) treatment. This evidence concerns the gene EPO and Alzheimer disease.